Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women

Journal of the National Cancer Institute

Volumn 87, Issue 7, 1995, Pages 517-523

  Calle, Eugenia E ^b   Miracle mcmahill, Heidi L ^b   Thun, Michael J ^b   Heath, Clark W ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; COLON CANCER; COLORECTAL CANCER; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE;

AGED; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMAN; MIDDLE AGE; ODDS RATIO; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; UNITED STATES;

EID: 0028943552     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/87.7.517     Document Type: Article

References (41)

1. McMichael AJ, Potter JD: Reproduction, endogenous and exogenous sex hormones, and colon cancer a review and hypothesis. J Natl Cancer Inst 65:1201-1207,1980.
2. McMichael AJ, Potter JD: Do intrinsic sex differences in lower alimentary tract physiology influence the sex-specific risks of bowel cancer and other biliary and intestinal diseases? Am J Epidemiol 118:620-627, 1983.
3. McMichael AJ, Potter JD: Host factors in carcinogenesis: certain bile-acid metabolic profiles that selectively increase the risk of proximal colon cancer. J Natl Cancer Inst 75:185-191, 1985.
4. Narisawa T, Magadia NE, Weisburger JH, et al: Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of A'-methyl-N'-nitro-N-nitrosoguanidine in rats. J Natl Cancer Inst 53:1093-1097, 1974.
5. Reddy BS, Watanabe K, Weisburger JH, et al: Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res 37:3238-3242, 1977.
6. Hill MJ: Bile acids in colorectal carcinogenesis. In Banbury Report No. 7. Gastrointestinal Cancer. Endogenous Factors (Bruce WR, Correa P, Lipkm M, et al, eds). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1981, pp 365-377.
7. Lynn J, Williams L, O’Brien J, et al: Effects of estrogen upon bile: implications with respect to gallstone formation. Ann Surg 178:514-524, 1973.
8. Davis RA, Kern F Jr.: Effects of ethinyl estradiol and phénobarbital on bile acid synthesis and biliary bile acid and cholesterol excretion. Gastroenterology 70:1130-1135,1976.
9. Pertsemlidis D, Panveliwalla D, Ahrens EH Jr.: Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man. Gastroenterology 66:565-573, 1974.
10. Bennion LJ, Ginsberg RL, Gemick MB, et al: Effects of oral contraceptives on the gallbladder bile of normal women. N Engl J Med 294:189-192, 1976.
11. Surgically confirmed gallbladder disease, venous thromboembolism, and breast tumors in relation to postmenopausal estrogen therapy. A report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. NEnglJMed 290:15-19, 1974.
12. Gallbladder disease as a side effect of drugs influencing lipid metabolism. Experience in the Coronary Drug Project. N Engl J Med 296:1185-1190, 1977.
13. Francavilla A, Di Leo A, Polimeno L, et al: Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding noncancerous colonic tissue. Gastroenterology 93:1301-1306,1987.
14. Meggouh F, Lointier P, Pezet D, et al: Status of sex steriod hormone receptors in large bowel cancer. Cancer 67:1964-1970, 1991.
15. Meggouh F, Lointier P, Saez S: Sex steroid and 1,25-dihydroxy vitamin D3 receptors in human colorectal adenocarcinoma and normal mucosa. Cancer Res51:1227-1233,1991.
16. Takeda H, Yamakawa M, Takahashi T, et al: An immunohistochemical study with an estrogen receptor-related protein (ER-D5) in human colorectal cancer. Cancer 69:907-912, 1992.
17. Murakami H, Masui H: Hormonal control of human colon carcinoma cell growth in serum-free medium. Proc Natl Acad Sci U S A 77:3464-3468, 1980.
18. Lointier P, Wildrick DM, Boman BM: The effects of steroid hormones on a human colon cancer cell line in vitro. Anticancer Res 12:1327-1330, 1992.
19. Jacobs EJ, White E, Weiss NS: Exogenous hormones, reproductive history, and colon cancer (Seattle, Washington, USA). Cancer Causes Control 5:359-366,1994.
20. Bostick RM, Potter JD, Kushi LH, et al: Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control 5:38-52, 1994.
21. Gerhardsson de Verdier M, London S: Reproductive factors, exogenous female hormones, and colorectal cancer by subsite. Cancer Causes Control 3:355-360,1992.
22. Newcomb PA, Storer BE, Marcus PM: Cancer of the large bowel in relation to use of hormone replacement therapy. Am J Epidemiol 136:958, 1992.
23. Chute CG, Willett WC, Colditz GA, et al: A prospective study of reproductive history and exogenous estrogens on the risk of colorectal cancer in women. Epidemiology 2:201-207, 1991.
24. Fumer SE, Davis FG, Nelson RL, et al: A case-control study of large bowel cancer and hormone exposure in women. Cancer Res 49:4936-4940, 1989.
25. Rosenberg L, Werler MM, Kaufman DW, et al: Cancers of the colon and rectum in relation to reproductive factors. Am J Epidemiol 126:760-761, 1987.
26. Potter JD, McMichael AJ: Large bowel cancer in women in relation to reproductive and hormonal factors: a case-control study. J Natl Cancer Inst 71:703-709,1983.
27. Burch JC, Byrd BF, Vaughn WK: The effects of long-term estrogen administration to women following hysterectomy. In Estrogens m the Postmenopause. Frontiers of Hormone Research, vol 3 (Van Keep PA, Lauritzen C, eds). Basel: Karger, 1975, pp 208-214.
28. Peters RK, Pike MC, Chang WW, et al: Reproductive factors and colon cancers. Br J Cancer 61:741-748, 1990.
29. Davis FG, Fumer SE, Persky V, et al: The influence of parity and exogenous female hormones on the risk of colorectal cancer. Int J Cancer 43:587-590,1989.
30. Wu AH, Paganini-Hill A, Ross RK, et al: Alcohol, physical activity and other risk factors for colorectal cancer a prospective study. Br J Cancer 55:687-694,1987.
31. Weiss NS, Daling JR, Chow WH: Incidence of cancer of the large bowel in women in relation to reproductive and hormonal factors. J Natl Cancer Inst 67:57-60, 1981.
32. Wu-Williams AH, Lee M, Whittemore AS, et al: Reproductive factors and colorectal cancer risk among Chinese females. Cancer Res 51:2307-2311, 1991.
33. Calle EE, Terrell DD: Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol 137:235-241, 1993.
34. World Health Organization: International Classification of Diseases: Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death, vol 1,9th rev. Geneva: WHO, 1977.
35. Cox DR: Regression models and life tables. J R Stat Soc (Series B) 34:187-220,1972.
36. Thun MJ, Calle EE, Namboodiri MM, et al: Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst 84:1491-1500, 1992.
37. Kleinbaum DG, Kupper LL, Morgenstern H: Epidemiologic Research: Principles and Quantitative Methods. Belmont, Calif: Lifetime Learning Publications, 1982.
38. Derby CA, Hume AL, Barbour MM, et al: Correlates of postmenopausal estrogen use and trends through the 1980s in two southeastern New England communities. Am J Epidemiol 137:1125-1135, 1993.
39. Egeland GM, Matthews KA, Kuller LH, et al: Characteristics of noncontraceptive hormone users. Prev Med 17:403-411, 1988.
40. Barrett-Connor E: Postmenopausal estrogen and prevention bias [see comment citation in Medline]. Ann Intern Med 115:455-456, 1991.
41. Bufill JA: Colorectal cancer: evidence for distinct genetic categories based on proximal and distal tumor location [see comment citation in Medline]. Ann Intern Med 113:779-788, 1990.